BACKGROUND: During a continuous femoral nerve block, the influence of catheter tip position relative to the femoral nerve on infusion characteristics remains unknown. METHODS: We inserted bilateral femoral perineural catheters in volunteers (ultrasound-guided, needle in-plane). Subjects' dominant side was randomized to have the catheter tip placed either anterior or posterior to the femoral nerve. The contralateral limb received the alternative position. Ropivacaine 0.1% was administered through both catheters concurrently for 6 hours (4 mL/h). Outcome measures included the maximum voluntary isometric contraction (MVIC) of the quadriceps femoris muscle and tolerance to cutaneous electrical current over to the distal quadriceps tendon. Measurements were performed at hour 0 (baseline), and on the hour until hour 9, as well as hour 22. The primary end point was the MVIC of the quadriceps at hour 6. RESULTS: As a percentage of the baseline measurement, quadriceps MVIC for limbs with anterior (n ϭ 16) and posterior (n ϭ 16) catheter tip placement did not differ to a statistically significant degree at hour 6 (mean [SD] 29% [26] vs 30% [28], respectively; 95% confidence interval: Ϫ22% to 20%; P ϭ 0.931), or at any other time point. However, the maximum tolerance to cutaneous electrical current was higher in limbs with anterior compared with posterior catheter tip placement at hour 6 (20 [23] mA vs 6 [4] mA, respectively; 95% confidence interval: 1-27 mA; P ϭ 0.035), as well as at hours 1, 7, 8, and 9 (P Ͻ 0.04). CONCLUSIONS: This study documents the significant (70%-80%) quadriceps femoris weakness induced by a continuous femoral nerve block infusion at a relatively low dose of ropivacaine (4 mg/h) delivered through a perineural catheter located both anterior and posterior to the femoral nerve. In contrast, an anterior placement increases cutaneous sensory block compared with a posterior insertion, without a concurrent relative increase in motor block. (Anesth Analg 2012; 115:721-7)
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We therefore tested the hypothesis that differing the location of the perineural catheter tip relative to the femoral nerve (anterior versus posterior) during cFNB impacts quadriceps muscle strength.
METHODS Enrollment
Our local IRB (University of California San Diego, San Diego, CA) approved all study procedures. The trial was prospectively registered at clinicaltrials.gov (NCT01263249). Enrollment included a convenience sample of relatively healthy adult volunteers (aged 18 years and older) of both sexes. Exclusion criteria included current daily analgesic use; any opioid use within the previous 4 weeks; any neuromuscular deficit of either femoral nerves and/or thigh musculature; body mass index Ͼ30 kg/m 2 ; pregnancy; and incarceration. Of note, any individual (e.g., medical trainees, study coordinators) whose nonstudy performance was potentially evaluated by the Principal Investigator (BI) was considered part of a "vulnerable population" and excluded from volunteering as a study subject as mandated by current United States ethical guidelines. 13 All participants provided written, informed consent before any study procedures. This study was undertaken in a Clinical and Translational Research Institute (University of California, San Diego, CA).
In the supine position, subjects had an IV line placed in the upper extremity, standard American Society of Anesthesiologists-recommended external monitors applied, and oxygen administered by nasal cannula (3 L/min). IV midazolam (1 mg) and fentanyl (50 g) were administered, while ensuring that study subjects remained responsive to verbal cues. Any hair in the area that would be subsequently covered by the catheter dressings was removed with a surgical hair clipper. After skin disinfection (chlorhexidine gluconate and isopropyl alcohol) and draping, bilateral femoral perineural catheters were inserted.
Randomization
Subjects acted as their own controls: The dominant side (right or left) was randomized to 1 of 2 treatment groups: perineural catheter tip placement immediately anterior or posterior to the femoral nerve. On the nondominant contralateral side, the catheter tip was placed in the other possible position relative to the femoral nerve. Randomization was based on computer-generated codes in blocks of 2, stratified by sex. The Investigational Drug Service prepared the randomization list and provided the investigator inserting each catheter with the treatment assignment immediately preceding catheter insertion. For each subject, all clinical personnel and the subject him/herself were masked to treatment group, other than the investigator(s) inserting the catheters.
Catheter Insertion
The dominant side (right versus left) catheter was always inserted first. With a 13-6 MHz 38-mm linear array transducer (HFL 38x; SonoSite M-Turbo, Bothell, WA) in a sterile sleeve, the femoral nerve was identified in a transverse cross-sectional (short-axis) view at the inguinal crease. A local anesthetic skin wheal was raised lateral to the ultrasound transducer. An uninsulated, 8.9-cm, 17-gauge, Tuohy-tip needle (FlexTip Plus; Teleflex Medical, Research Triangle Park, NC) was inserted through the skin wheal and directed medially in-plane beneath the ultrasound transducer to either immediately anterior or posterior to the femoral nerve with an anterior bevel direction. Normal saline (5-10 mL) was injected as the needletip approached the lateral edge of the femoral nerve to open the space between the nerve and overlying fascia (anterior) or underlying muscle (posterior) to avoid needle-nerve contact. The needle was advanced until the tip was at the midpoint of the visualized femoral nerve, at which time a 19-gauge, flexible, epidural-type, open-tip catheter (FlexTip; Teleflex Medical) was inserted through the length of the needle and advanced 1 cm beyond the needletip (Fig. 1 ). With the catheter tip remaining visualized by ultrasound to ensure that its position remained fixed, the needle was withdrawn over the catheter until the needletip was superficial to the iliac fascia. The needle was then held in place and 2 cm of catheter inserted above the iliac fascia while ensuring that the catheter tip remained stationary. The needle was then withdrawn over the remaining catheter. The injection port was attached to the catheter and the catheter secured with sterile liquid adhesive, an occlusive dressing, and an anchoring device.
This procedure was repeated in the nondominant leg and the catheter was inserted in the alternative position relative to the femoral nerve. The same volume of normal saline used in the first insertion was injected via the needle for hydrodissection. If this second catheter insertion required a higher volume of normal saline than the initial insertion, the difference in volume was subsequently injected via the initial catheter. This protocol resulted in equal volumes of normal saline bilaterally.
Perineural Infusion
The Investigational Drug Service prepared and delivered to the investigators 2 identical infusion pumps (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, St. Paul, MN) with 100 mL of 0.1% ropivacaine programmed to administer a continuous infusion of 4 mL/h (4 mg/h) for 6 hours. At hour 0, each infusion pump administered a 2-mL bolus to fill the "dead space" of the catheter hubs and lengths, and subsequently initiated the basal infusions. The infusion pumps were turned off at hour 6, and the perineural catheters were removed.
Subjects remained in the Clinical and Translational Research Institute for 23 hours, or until their quadriceps femoris strength had returned to baseline levels, whichever was longer.
Outcome Measurements
We selected measures that have established reliability and validity, 3,6,14 -16 and minimal interrater discordance. 15 Measurements were performed at hour 0 (baseline), and on the hour until hour 9, as well as the next morning at approximately hour 22. In all cases, measurements were taken in the seated position with the dominant side measured first, followed by the nondominant side. Initially, quadriceps femoris strength was evaluated with a single measurement, followed by tolerance of transcutaneous electrical stimulation 0 to 1 cm medial to the distal quadriceps tendon with a single measurement. The primary end point was the difference in maximum voluntary isometric contraction (MVIC) of the quadriceps femoris expressed as a percentage of the baseline measurement 6 hours after initiation of local anesthetic administration. Secondary end points included quadriceps femoris MVIC at other time points and cutaneous sensation 0 to 1 cm medial to the distal quadriceps tendon in the 22 hours after initiation of local anesthetic administration.
Muscle Strength
We evaluated quadriceps femoris muscle strength with an isometric force electromechanical dynamometer (Micro-FET2; Lafayette Instrument Company, Lafayette, IN) to measure the force produced during an MVIC in a seated position with the knees flexed at 90°. 15 The dynamometer was placed on the ipsilateral anterior tibia perpendicular to the tibial crest just proximal to the medial malleolus. 14 -16 For all measurements, subjects were asked to take 2 seconds to come to maximum effort contracting the quadriceps femoris, maintain this effort for 5 seconds, and then relax. 6, 16 The measurements immediately before perineural ropivacaine administration were designated baseline measurements, and all subsequent measurements are expressed as a percentage of the preinfusion baseline. 6 
Tolerance of Transcutaneous Electrical Stimulation
We evaluated tolerance of transcutaneous electrical stimulation with the same quantitative procedure as one described previously. 8 Electrocardiogram pads were placed 0 to 1 cm medial to the distal quadriceps tendon and attached to a nerve stimulator (EZstimII, Model ES400; Life-Tech, Stafford, TX). The current was delivered as a tetanic stimulus (50 Hz) increased from 0 mA until subjects detected the electrical current (up to a maximum of 80 mA), at which time the current was recorded and the nerve stimulator turned off.
Statistical Analysis
Sample size calculations were based on our primary aim to determine the effect of ropivacaine administration site (anterior versus posterior relative to the femoral nerve) but at an equivalent rate/dose when used in cFNB. To this end, the primary end point was designated as the quadriceps femoris MVIC expressed as a percentage of the baseline MVIC at hour 6. A 1-sample t test of the side-to-side difference (equivalent to a paired t test) was used to determine whether quadriceps MVIC differed significantly by site of administration. A difference of 20 percentage points was considered clinically relevant because a 10% side-to-side strength difference is common, yet functionally unnoticeable in healthy individuals. 17, 18 Based on previously published data, 9 we assumed the standard deviation of side-to-side difference in percent change from baseline in MVIC to be approximately 27%. Under these assumptions, a trial with n ϭ 16 subjects has 80% power, with a 2-sided ␣ ϭ 5%, to detect an effect of ␦ ϭ 20% (StatMate; GraphPad Software, San Diego, CA). To assess the normality assumption underlying the primary t test analysis, we examined box and whisker plots, density plots, and normal quantilequantile plots, and submitted the data to Shapiro-Wilks tests of normality. Where the Shapiro-Wilks test indicated deviation from normality, we performed a nonparametric bootstrap sensitivity analysis, resampling with replacement 1000 times, to generate 95% confidence intervals (CIs) for the mean.
The same analysis of percent change from baseline at hour 6 was applied to the secondary MVIC outcome measures, and raw electrical current values at all time points. Profiles of the responses over time were examined with spaghetti and mean plots. Further secondary analyses included mixed-effects modeling of the repeated hourly measures to confirm the analysis of percent change at 6 hours. These models account for the hierarchical correlation of paired measures from each subject over time, and were used to test the effects of subject characteristics, including handedness, sex, height, weight, body mass index, and age. The model also allowed simultaneous analysis of all observations while accounting for withinsubject correlation, which can more accurately estimate the standard errors of the estimated differential at each hour. The within-subject correlation was modeled via a subjectspecific random intercept. This is similar to a compound symmetric correlation structure without a random effect. The change from baseline, Y, for subject i and time t j was modeled with the linear mixed-effect model:
where 1{t j ϭ k} is 1 if t j ϭ k and 0 otherwise. The subject-specific random intercepts b i and residuals e ij were assumed to follow a Gaussian distribution. We present the estimated difference at each hour with unadjusted P values, and P values adjust using the single-step method for simultaneous inference from parametric models. These analyses were executed using R version 2.12 (2010). a
Because this was a pharmacodynamics study, as opposed to an outcomes trial, we prospectively elected to exclude from the primary analyses subjects in whom catheter tip dislodgement/failure was a probability (as opposed to intention-to-treat analysis optimally used in outcomes trials). Perineural catheter dislodgement/failure was defined as a decrease Ͻ20% from baseline in motor strength of the ipsilateral quadriceps femoris muscle or sensory perception in the ipsilateral femoral nerve distribution within the first 6 hours after local anesthetic initiation. For unsuccessful perineural catheter insertion or if a perineural catheter was inadvertently dislodged before the measurement of the primary end point, the data for that subject (both catheters) would not be included in the analysis.
RESULTS
Seventeen subjects enrolled during a 3-month period beginning January 2011 ( Table 1 ). All had bilateral femoral perineural catheters successfully inserted per protocol. There were no catheter failures or adverse events. The fourth subject was excluded from analysis the day after the infusion when it was determined that her measurements were faulty because of an imprecise data-capture technique. We enrolled a 17th subject to replace the fourth so that a total of 16 subjects could be included in the analysis to adhere to the a priori sample size estimation. No additional protocol deviations occurred. The mean difference between anterior and posterior quadriceps MVIC at baseline was 1.09 (95% CI: Ϫ0.83 to 3.01, 1-sample t test, P ϭ 0.243).
Quadriceps MVIC for limbs with anterior (n ϭ 16) and posterior (n ϭ 16) catheter tip placement did not differ to a statistically significant degree at hour 6 (mean [SD] 29% [26] vs 30% [28], respectively; 95% CI: Ϫ22%-20%; P ϭ 0.931), or any other time point (Fig. 2) . However, the maximum tolerance to cutaneous electrical current was higher in limbs with anterior versus posterior catheter tip placement at hour 6 (20 [23] mA vs 6 [4] mA, respectively; 95% CI: 1-27 mA; P ϭ 0.035), as well as hours 1, 7, 8, and 9 (P Ͻ 0.04; Fig. 3 ). The Shapiro-Wilks test indicated that the tolerance data was not normal at all hours (P Ͻ 0.003), so we estimated 95% CIs for the means using the nonparametric bootstrap. The bootstrap results were consistent with the prespecified t test analysis at hour 6 (95% CI: 4.3-26.6 mA), and found significant differences at all hours except hour 22 (Fig. 4) .
The mixed-effects models were largely consistent with the simple 1-sample t test analysis performed at each hour (Tables 2 and 3 ). However, reduced unexplained variance resulted in smaller P values (Ͻ0.001 for sensory at hours 6 -8), including a statistically significant sensory effect at hour 5 (P ϭ 0.009). Summary statistics are provided in Table 4 .
DISCUSSION
This randomized, subject/observer-masked, split-body, controlled investigation documents the significant (70%-80%) . Effects of perineural catheter tip position relative to the femoral nerve (anterior versus posterior) on tolerance of transcutaneous electrical current in the femoral nerve distribution. Ropivacaine, 0.1%, was infused for 6 hours at 4 mL/h bilaterally. Mean (SE) values are illustrated. Statistically significant differences between treatments at 95% confidence are designated with an asterisk ( § denotes a statistically significant difference between treatments at 95% confidence exclusively with the mixed-effects models). Values are reported as mean (SD) or number of subjects.
Anterior Versus Posterior Femoral Catheter Insertion quadriceps femoris weakness induced by a cFNB infusion at a relatively low dose of ropivacaine delivered through perineural catheters located both anterior and posterior to the femoral nerve. In contrast, an anterior placement increases tolerance of transcutaneous electrical stimulation (350%) compared with a posterior insertion (50%), without a concurrent relative increase in motor block. To our knowledge, this is the first report of a successful approach to influence the motorsensory ratio during cFNB, with possible implications for postoperative ambulating patients as well as perineural local anesthetic infusion research, in general.
Clinical Significance
Although falls certainly occur in patients without a regional anesthetic/analgesic after orthopedic procedures of the lower extremity, 19 there is growing evidence that lower extremity continuous peripheral nerve blocks may increase the risk of these adverse events. 20 -23 The primary mechanism is currently unknown, and may be induced motor weakness, sensory block, a proprioception deficit, or another factor yet unidentified. Nonetheless, weakness of the knee extensor muscles during cFNB severely limits postoperative rehabilitation, 5 itself a critical component in optimizing joint function after total knee arthroplasty. 24 Although the current study did not find a motor-sparing benefit in altering perineural catheter location relative to the femoral nerve, the possibility of improved analgesia with an infusion anterior to this nerve may permit a lower local anesthetic dose than would be required with a posteriorly inserted catheter.
Study Limitations
Central to this issue, the current study measured cutaneous sensation just medial to the distal quadriceps tendon in healthy volunteers. By including only nonsurgical subjects, we were able to exclude postoperative pain as a confounding variable, allowing isolation of the variable catheter location effects on muscle strength and cutaneous sensation. Of course, the inclusion of nonsurgical volunteers also makes extrapolation to clinical practice problematic. Whether cutaneous sensation correlates well with postoperative pain after various knee procedures remains unknown. Answering this question will require studying patients after numerous types of surgical procedures, and the results of the current study should be viewed as a reference point to help design future clinical trials. Similarly, the approximately 70% decrease in quadriceps femoris MVIC with a relatively low dose of ropivacaine suggests that additional decreases in local anesthetic dose may be desirable to further limit infusion-induced quadriceps weakness, but it remains unknown whether such a low dose of ropivacaine would provide adequate postoperative analgesia. Further study is required to investigate why an anterior catheter location resulted in more cutaneous anesthesia than a catheter in the posterior position. Furthermore, all subjects remained supine during the period of perineural infusion (except during hourly measurements), unlike ambulating postoperative patients; to what degree this difference may have on our results remains unclear. Lastly, visualizing the perineural catheter tip using a needle in-plane (short axis) approach of the femoral nerve is relatively easy in comparatively thin, healthy volunteers. However, this maneuver is far more challenging (often impossible) using alternative ultrasound approaches, in patients with larger body mass indexes, and for deeper nerves requiring a steeper needle trajectory. 25 Finally, the results of the current study may not be applicable to other local anesthetics, 26 infusion durations, or ropivacaine doses, the latter being important because the degree of postoperative analgesia provided by ropivacaine at 4 mL/h remains undetermined. 27 
Summary
This study documents the significant (70%-80%) quadriceps femoris weakness induced by a cFNB infusion at a relatively low dose of ropivacaine (4 mg/h) delivered through a perineural catheter located both anterior and posterior to the femoral nerve. In contrast, an anterior placement increases cutaneous sensory block compared with a posterior insertion, without a concurrent relative increase in motor block. These findings both demonstrate a beneficial aspect of ultrasound-guided catheter insertion, and suggest that important clinical benefits may be attainable for postoperative ambulating patients. Additional study within a surgical population is warranted because of limitations of the volunteer subject model of the present investigation. 
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